|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net (loss) income | |||||
| Adjustments for: | |||||
| Amortization of deferred financing costs and debt guarantee, net | |||||
| Depreciation and amortization | |||||
| (Earnings) losses of equity method investees | |||||
| Dividends received from equity method investees | |||||
| Change in market value of derivatives | |||||
| Current expected credit losses | |||||
| Deferred taxes | |||||
| Share-based compensation | |||||
| Asset impairment expense | |||||
| Goodwill impairment expense | |||||
| Earnings recognized from vessels chartered to third parties transferred to Energos | |||||
| Loss on the disposal of equity method investment | |||||
| (Gain) loss on sale of assets, net | |||||
| Loss on extinguishment of debt, net | |||||
| Loss on sale of net investment in lease | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| (Increase) decrease in receivables | |||||
| (Increase) in inventories | |||||
| (Increase) decrease in other assets | |||||
| Decrease in right-of-use assets | |||||
| Increase in accounts payable/accrued liabilities | |||||
| (Decrease) in lease liabilities | |||||
| Increase (decrease) in other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Cash paid for business combinations, net of cash acquired | |||||
| Entities acquired in asset acquisitions, net of cash acquired | |||||
| Proceeds from sale of net investment in lease | |||||
| Sale of Jamaica Business | |||||
| Sale of vessels to Energos | |||||
| Sale of equity method investment | |||||
| Other asset sales | |||||
| Sale of Miami Facility | |||||
| Other investing activities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from borrowings of debt | |||||
| Payments made for capital expenditures paid beyond customary vendor payment terms | |||||
| Repayment of debt | |||||
| Payments related to tax withholdings for share-based compensation | |||||
| Payment of deferred financing costs | |||||
| Payment of dividends | |||||
| Issuance of Class A stock | |||||
| Other financing activities | |||||
| Net cash (used in) provided by financing activities | |||||
| Impact of changes in foreign exchange rates on cash and cash equivalents | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash – beginning of period | |||||
| Cash, cash equivalents and restricted cash – end of period | |||||
| Cash paid for interest, net of capitalized interest | |||||
| Cash paid for taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Changes in accounts payable and accrued liabilities associated with construction in progress and property, plant and equipment additions | |||||
| Liabilities associated with consideration paid for entities acquired in asset acquisitions | |||||
| Consideration paid in shares for business combinations | |||||
| Accounts payable and accrued liabilities associated with construction in progress and property, plant and equipment additions | |||||
| Principal payments on financing obligation paid to Energos by third party charters | |||||
| Non-cash settlement of Vessel Financing Obligation | |||||
| Proceeds held in escrow | |||||
| Accrued dividend | |||||
| Preferred shares issued and debt assumed in PortoCem acquisition | |||||
| Fair value of contingent payments in the Lins acquisition | |||||
| Deemed dividend related to Series B preferred stock | |||||
| Non-cash financing costs | |||||
| Consideration received on asset sale | |||||
| Shares received in Hilli Exchange | |||||
| Investment in Energos | |||||
| Cash and cash equivalents | |||||
| Current restricted cash | |||||
| Non-current restricted cash | |||||
| Cash and cash equivalents classified as held for sale | |||||
Loading...